论文部分内容阅读
近日,葛兰素史克(GSK)的人乳头状瘤病毒(HPV)疫苗“希瑞适”获得中国国家食品药品监督管理总局的上市许可,成为中国内地首个获批预防子宫颈癌的HPV疫苗。HPV与子宫颈癌有何关系?为何是9~25岁女性适合接种?打了子宫颈癌疫苗就不会再患子宫颈癌了吗?著名癌症防治专家、国家癌症中心/中国医学科学院肿瘤医院流行病学研究室主任乔友林教授对此一一解读。
Recently, GlaxoSmithKline’s Human Papilloma Virus (HPV) vaccine “Siritchit” was approved by China’s State Food and Drug Administration as a permit to become the first Chinese woman approved for the prevention of cervical cancer HPV vaccine. HPV and cervical cancer what is the relationship? Why 9 to 25-year-old woman suitable for vaccination? Hit the cervical cancer vaccine will not suffer from cervical cancer yet? Well-known cancer experts, the National Cancer Center / Chinese Academy of Medical Oncology Hospital Professor Qiao Youlin, director of Epidemiology Laboratory, explains this.